Diabetes patients could be aided in recovering from heart attacks by a common drug already on the market, health researchers have claimed.
Heart disease is the leading cause of illness for people suffering from diabetes, accounting for more than half of all fatalities.
But a study into the drug metformin, a key treatment used by diabetic patients to prevent heart disease, found it enhances the physiological process behind new blood vessel formation, which is essential for heart attack recovery.
The study, done in conjunction with King Abdulaziz University, Jeddah, Saudi Arabia, showed that lack of oxygen in the presence of high glucose levels delays blood vessel formation but metformin reverses that process.
Metformin is a drug usually used as a first-line treatment in Type 2 diabetes as it helps to make the body more responsive to insulin.
The International Diabetes Federation has said that 8.3% of adults have diabetes, affecting 382 million worldwide, and it is estimated that this will rise to 592 million by 2035.